Study #2018-0663
Fecal Microbiota Transplantation (FMT) for Immune-Checkpoint Inhibitor Induced-Diarrhea/Colitis in Cancer Patients
MD Anderson Study Status
Enrolling
Treatment Agent
Loperamide
Description
This trial studies how well fecal microbiota transplantation works in treating diarrhea or colitis (inflammation of the intestines) that is caused by certain types of medications (called immune-checkpoint inhibitors) in patients with genitourinary cancer. Fecal microbiota transplantation may effectively reduce the incidence of immune checkpoint inhibitor-induced diarrhea/colitis.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Colitis, Diarrhea, Malignant Genitourinary System Neoplasm, Melanoma, Lung Cancer, Ovarian Cancer, Uterine Cancer, Breast Cancer, Cervical Cancer
Study phase:
Phase I
Physician name:
Yinghong Wang
Department:
Gastroenterology Hepat & Nutr
For general questions about clinical trials:
1-866-671-2559
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.